US sales News
US sales to aid growth
Growth from branded formulations and the US business will hold the key for Dr Reddy's Laboratories, while the fallout of the JB Chemicals deal will have negligible impact on the Russian and Commonwealth of Independent States (CIS) markets. The growth story stays intact, though the stock has declined 8.3 per cent during the September quarter, in line with the decline in the healthcare index, due to
US sales Galleries
|
|
